A Claudin-Targeting Molecule as an Inhibitor of Tumor Metastasis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2010-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.110.168070PMID 20442222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel Tumor-Targeted Therapy Using a Claudin-4-Targeting Molecule

  2009cited by this paper
• Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.

  2009cited by this paper
• Altered gene expression in breast cancer liver metastases

  2009cited by this paper
• Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival

  2009cited by this paper
• Therapeutic antitumor efficacy of monoclonal antibody against Claudin‐4 for pancreatic and ovarian cancers

  2009cited by this paper
• Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors

  2009cited by this paper
• Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression.

  2008cited by this paper
• Smad7 induces hepatic metastasis in colorectal cancer

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Expression of tight junction-associated proteins in human gastric cancer : down regulation of claudin-4 correlates with tumor aggressiveness and survival

  2008cited by this paper
• Cell polarity in development and cancer

  2007cited by this paper
• Overexpression of claudin‐3 and claudin‐4 receptors in uterine serous papillary carcinoma

  2007cited by this paper
• Expression of tight junction associated proteins in human gastric cancer: Reduced expression of Claudin-4 correlates with tumor aggressiveness and survival

  2007cited by this paper
• Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis.

  2007cited by this paper
• Cancer metastasis: building a framework.

  2006cited by this paper
• Tumor metastasis: mechanistic insights and clinical challenges

  2006cited by this paper
• Immunotoxins in the treatment of hematologic malignancies.

  2006cited by this paper
• Claudins: emerging targets for cancer therapy

  2006cited by this paper
• Claudins in occluding junctions of humans and flies.

  2006influential reference
• GATA factors in vertebrate heart development and disease

  2006cited by this paper
• RNA repair for haemophilia A

  2006cited by this paper
• Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study

  2005cited by this paper
• Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.

  2005cited by this paper
• Induction of claudin-4 by nonsteroidal anti-inflammatory drugs and its contribution to their chemopreventive effect.

  2005cited by this paper
• Claudin proteins in human cancer: promising new targets for diagnosis and therapy.

  2005cited by this paper
• Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity.

  2005cited by this paper
• Mammalian tight junctions in the regulation of epithelial differentiation and proliferation.

  2005cited by this paper
• Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

  2005cited by this paper
• Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

  2004cited by this paper
• New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin.

  2004cited by this paper
• Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins.

  2003cited by this paper
• Segregation of receptor and ligand regulates activation of epithelial growth factor receptor

  2003cited by this paper
• Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.

  2003cited by this paper
• Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands : Evidence for direct involvement of claudins in tight junction barrier

  2002cited by this paper
• Intravascular location of breast cancer cells after spontaneous metastasis to the lung.

  2002cited by this paper
• Tight junctions and their role in cancer metastasis.

  2001cited by this paper
• Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

  2001cited by this paper
• Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands

  1999cited by this paper
• Increased tight junctional permeability is associated with the development of colon cancer.

  1999cited by this paper
• Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands.

  1999cited by this paper
• Molecular architecture of tight junctions.

  1998cited by this paper
• Cell adhesion molecules and cancer metastasis.

  1997cited by this paper
• Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis.

  1997cited by this paper
• Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Further observations on the fine structure of freeze-cleaved tight junctions.

  1973cited by this paper

• Claudins: from gatekeepers of epithelial integrity to potential targets in hepato-pancreato-biliary cancers

  2024cites this paper
• Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy

  2023cites this paper
• Anti-tumor effect of a recombinant Bifidobacterium strain secreting a claudin-targeting molecule in a mouse breast cancer model.

  2020cites this paper
• Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation

  2017cites this paper
• The role of claudins in cancer metastasis

  2017cites this paper
• Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin

  2016cites this paper
• Baicalein Inhibits the Migration and Invasion of B16F10 Mouse Melanoma Cells through Inactivation of the PI3K/Akt Signaling Pathway

  2016cites this paper
• Structure and Function of Epithelial and Endothelial Barriers

  2016cites this paper
• Claudin‐4 binder C‐CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway

  2015cites this paper
• Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma

  2015cites this paper
• Pro-chemotherapeutic effects of antibody against extracellular domain of claudin-4 in bladder cancer.

  2015cites this paper
• Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.

  2014cites this paper
• TOPIC HIGHLIGHT

  2014cites this paper
• Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.

  2014cites this paper
• Recent advances in claudin-targeting technology.

  2013cites this paper
• Claudin-3 and Claudin-4 Regulate Sensitivity to Cisplatin by Controlling Expression of the Copper and Cisplatin Influx Transporter CTR1

  2013cites this paper
• Claudin-4 as therapeutic target in cancer.

  2012cites this paper
• Targeting claudin-4 in human pancreatic cancer

  2012cites this paper
• Proof of concept for claudin‐targeted drug development

  2012cites this paper
• Claudin-2 Promotes Breast Cancer Liver Metastasis by Facilitating Tumor Cell Interactions with Hepatocytes

  2012cites this paper
• Claudins and other tight junction proteins.

  2012cites this paper
• Creation and biochemical analysis of a broad-specific claudin binder.

  2012cites this paper
• Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment

  2011cites this paper
• Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors

  2011cites this paper
• Claudins and Ki-67

  2011cites this paper
• Expression of Claudins and Their Prognostic Significance in Noninvasive Urothelial Neoplasms of the Human Urinary Bladder

  2011cites this paper
• Claudins in lung diseases

  2011cites this paper
• Specificity of Interaction between Clostridium perfringens Enterotoxin and Claudin-Family Tight Junction Proteins

  2010cites this paper